{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:15:41Z","timestamp":1790914541223,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","annalsofvascularsurgery.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.avsg.2018.05.036","type":"journal-article","created":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T00:18:23Z","timestamp":1532477903000},"page":"190-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Peripheral Blood Mononuclear Cells Therapy for Treatment of Lower Limb Ischemia in Diabetic Patients: A Single-Center Experience"],"prefix":"10.1016","volume":"53","author":[{"given":"Francesca","family":"Persiani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Paolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Camilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Mascellari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Platone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Magenta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Furgiuele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2018.05.036_bib1","first-page":"49","article-title":"The prognosis of non-critical imb ischaemia: a systematic review of population-based evidence","volume":"49","author":"Hooi","year":"1999","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.avsg.2018.05.036_bib2","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-society consensus for the management of peripheral arterial disease (TASC II)","volume":"45 Suppl S","author":"Norgren","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2018.05.036_bib3","first-page":"e463","article-title":"ACC\/AHA2005. Practice Guidelines for the management of patients with peripheral arterial disease","volume":"113","author":"Hirsch","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2018.05.036_bib4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/dmrr.2399","article-title":"Both autologous bone marrow mononuclear cell and peripheral blood progenitor cell therapies similarly improve ischaemia in patients with diabetic foot in comparison with control treatment","volume":"29","author":"Dubsky","year":"2013","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.avsg.2018.05.036_bib5","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1177\/152660280701400520","article-title":"TASC II section F on revascularization in PAD","volume":"14","author":"Norgren","year":"2007","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2018.05.036_bib6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.numecd.2013.12.007","article-title":"Treatment of peripheral arterial disease in diabetes: a consensus of the Italian Societies of diabetes (SID, AMD), Radiology (SIRM) and vascular endovascular Surgery (SICVE)","volume":"24","author":"Aiello","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.avsg.2018.05.036_bib7","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/01.CIR.0000058702.69484.A0","article-title":"Peripheral blood \u201cendothelial progenitor cells\u201d are derived from monocyte\/macrophages and secrete angiogenic growth factors","volume":"107","author":"Rehman","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2018.05.036_bib8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0140-6736(02)09670-8","article-title":"Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial","volume":"360","author":"Tateishi-Yuyama","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.avsg.2018.05.036_bib9","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1126\/science.275.5302.964","article-title":"Isolation of putative progenitor endothelial cells for angiogenesis","volume":"275","author":"Asahara","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.avsg.2018.05.036_bib10","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1161\/01.CIR.0000031332.45480.79","article-title":"Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs","volume":"106","author":"Iba","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2018.05.036_bib11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1172\/JCI119877","article-title":"Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb","volume":"101","author":"Arras","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.avsg.2018.05.036_bib12","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/01.RES.0000122041.73808.B5","article-title":"Collateral artery growth (arteriogenesis) after experimental arterial occlusion is impaired in mice lacking CC-chemokine receptor-2","volume":"94","author":"Heil","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.avsg.2018.05.036_bib13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10456-013-9381-6","article-title":"Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in\u00a0vivo","volume":"17","author":"Jetten","year":"2014","journal-title":"Angiogenesis"},{"key":"10.1016\/j.avsg.2018.05.036_bib14","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1039\/C7IB00018A","article-title":"Deconvolution of heterogeneous wound tissue samples into relative macrophage phenotype composition via models based on gene expression","volume":"9","author":"Ferraro","year":"2017","journal-title":"Integr Biol (Camb)"},{"key":"10.1016\/j.avsg.2018.05.036_bib15","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0741-5214(97)70045-4","article-title":"Recommended standards for reports dealing with lower extremity ischemia:revised version","volume":"26","author":"Rutherford","year":"1997","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2018.05.036_bib16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00125-006-0491-1","article-title":"High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic footdisease in Europe. Baseline results from the Eurodiale study","volume":"50","author":"Prompers","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.avsg.2018.05.036_bib17","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.diabres.2012.04.016","article-title":"All-cause in-hospital mortality and comorbidity in diabetic and non-diabetic patients with stroke","volume":"98","author":"Braun","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.avsg.2018.05.036_bib18","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.2337\/dc06-0306","article-title":"Assessing the outcome of the management of diabetic foot ulcers using ulcer-related and person-related measures","volume":"29","author":"Jeffcoate","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.avsg.2018.05.036_bib19","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0140-6736(05)67704-5","article-title":"Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial","volume":"366","author":"Adam","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.avsg.2018.05.036_bib20","doi-asserted-by":"crossref","first-page":"484e90","DOI":"10.1016\/j.ejvs.2006.03.006","article-title":"Early and five-year amputation and survival rate of diabetic patients with critical limb ischemia: data of a cohort study of 564 patients","volume":"32","author":"Faglia","year":"2006","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2018.05.036_bib21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jvs.2010.08.060","article-title":"Treatment of peripheral arterial disease using stem and progenitor cell therapy","volume":"53","author":"Lawall","year":"2011","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2018.05.036_bib22","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0140-6736(02)11977-5","article-title":"Peripheral-blood or bone-marrow mononuclear cells for therapeutic angiogenesis?","volume":"360","author":"Minamino","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.avsg.2018.05.036_bib23","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/bmt.2010.110","article-title":"Bone marrow mononuclear cells versus G-CSF-mobilized peripheral blood mononuclear cells for treatment of lower limb ASO: pooled analysis for long-term prognosis","volume":"46","author":"Onodera","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.avsg.2018.05.036_bib24","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.jcyt.2015.04.006","article-title":"Characterization of the Pall Celeris system as a point-of-care device for therapeutic angiogenesis","volume":"17","author":"Spaltro","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.avsg.2018.05.036_bib25","doi-asserted-by":"crossref","first-page":"e93965","DOI":"10.1371\/journal.pone.0093965","article-title":"Vasoreparative Dysfunct CD34+ Cell diabetic individuals nvolves hypoxic desensitization impaired autocrine\/paracrine mechanisms","volume":"9","author":"Jarajapu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.avsg.2018.05.036_bib26","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1161\/01.ATV.0000203513.29227.6f","article-title":"Differential healing activities of CD34+ and CD14+ endothelial cell progenitors","volume":"26","author":"Awad","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.avsg.2018.05.036_bib27","first-page":"41","article-title":"Lesioni trofiche resistenti alla rivascolarizzazione nel paziente diabetico: prospettive terapeutiche innovative su base epigenetica","volume":"22","author":"Furgiuele","year":"2015","journal-title":"It J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2018.05.036_bib28","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1089\/ten.tec.2014.0245","article-title":"Limb rescue: a new autologous-peripheral bllod mononuclear cells technology in critical limb ischemia and chronic ulcers","volume":"21","author":"De Angelis","year":"2015","journal-title":"Tisssue Eng Pert C Methods"},{"key":"10.1016\/j.avsg.2018.05.036_bib29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jdiacomp.2011.11.007","article-title":"Therapeutical potential of autologous peripheral blood mononuclear cell transplantation in patients with type 2 diabetic critical limb ischemia","volume":"26","author":"Ozturk","year":"2012","journal-title":"J Diabet Complications"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509618305028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509618305028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T23:55:59Z","timestamp":1539042959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509618305028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":29,"alternative-id":["S0890509618305028"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2018.05.036","relation":{},"ISSN":["0890-5096"],"issn-type":[{"value":"0890-5096","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral Blood Mononuclear Cells Therapy for Treatment of Lower Limb Ischemia in Diabetic Patients: A Single-Center Experience","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2018.05.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}